25 XP   0   0   10

Personalis Inc
Buy, Hold or Sell?

Let's analyse Personalis together

PenkeI guess you are interested in Personalis Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Personalis Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Personalis Inc

I send you an email if I find something interesting about Personalis Inc.

Quick analysis of Personalis (30 sec.)










What can you expect buying and holding a share of Personalis? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.56
Expected worth in 1 year
$0.81
How sure are you?
16.7%

+ What do you gain per year?

Total Gains per Share
$-1.76
Return On Investment
-135.1%

For what price can you sell your share?

Current Price per Share
$1.30
Expected price per share
$0.92 - $1.54
How sure are you?
50%

1. Valuation of Personalis (5 min.)




Live pricePrice per Share (EOD)

$1.30

Intrinsic Value Per Share

$-25.88 - $-30.41

Total Value Per Share

$-23.32 - $-27.84

2. Growth of Personalis (5 min.)




Is Personalis growing?

Current yearPrevious yearGrowGrow %
How rich?$129.4m$252.9m-$90.3m-55.6%

How much money is Personalis making?

Current yearPrevious yearGrowGrow %
Making money-$27m-$28.3m$1.2m4.6%
Net Profit Margin-147.5%-175.1%--

How much money comes from the company's main activities?

3. Financial Health of Personalis (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#66 / 145

Most Revenue
#88 / 145

Most Profit
#126 / 145

Most Efficient
#116 / 145

What can you expect buying and holding a share of Personalis? (5 min.)

Welcome investor! Personalis's management wants to use your money to grow the business. In return you get a share of Personalis.

What can you expect buying and holding a share of Personalis?

First you should know what it really means to hold a share of Personalis. And how you can make/lose money.

Speculation

The Price per Share of Personalis is $1.3. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Personalis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Personalis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.56. Based on the TTM, the Book Value Change Per Share is $-0.44 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.46 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Personalis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.53-40.5%-0.54-41.2%-0.56-43.1%-0.35-26.9%-0.31-23.7%
Usd Book Value Change Per Share-0.43-33.2%-0.44-33.8%-0.46-35.1%0.2318.0%0.118.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.43-33.2%-0.44-33.8%-0.46-35.1%0.2318.0%0.118.2%
Usd Price Per Share2.10-1.99-4.15-12.00-10.00-
Price to Earnings Ratio-1.00--0.93--1.87--13.92--11.60-
Price-to-Total Gains Ratio-4.87--4.61--9.07--47.64--47.64-
Price to Book Ratio0.82-0.62-0.79-3.39-2.83-
Price-to-Total Gains Ratio-4.87--4.61--9.07--47.64--47.64-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.3
Number of shares769
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.440.23
Usd Total Gains Per Share-0.440.23
Gains per Quarter (769 shares)-337.64179.54
Gains per Year (769 shares)-1,350.56718.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1351-13610718708
20-2701-2712014361426
30-4052-4063021552144
40-5402-5414028732862
50-6753-6765035913580
60-8103-8116043094298
70-9454-9467050275016
80-10805-10818057455734
90-12155-12169064646452
100-13506-13520071827170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.024.00.00.0%0.024.00.00.0%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%4.017.03.016.7%4.017.03.016.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.024.00.0%0.00.024.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%4.016.00.020.0%4.017.03.016.7%4.017.03.016.7%

Fundamentals of Personalis

About Personalis Inc

Personalis, Inc. develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD) and recurrence in cancer; and ImmunoID NeXT, a tissue-based test that combines whole exome (DNA) and whole transcriptome (RNA) sequencing data with advanced analytics to provide a multi-dimensional view of the tumor and the tumor microenvironment from a single sample. It also provides NeXT Personal Dx, a tumor-informed liquid biopsy test for detection of MRD and recurrence in cancer; and NeXT Dx, a comprehensive tumor profiling test that unlocks the entire exome (DNA) and transcriptome (RNA) with matched tumor-normal analysis. In addition, the company performs whole exome sequencing (WES) of cancer tissue and matched blood samples for diagnostic companies as an input to their products; and whole genome sequencing (WGS) on human samples for research projects, such as population sequencing initiatives, as well as offers sequencing and data analysis services to support population sequencing initiatives. Its customers include pharmaceutical companies, biopharmaceutical companies, diagnostics companies, universities, non-profits, government entities, and patients. The company was incorporated in 2011 and is headquartered in Fremont, California.

Fundamental data was last updated by Penke on 2024-04-12 15:50:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Personalis Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Personalis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Personalis to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -135.1% means that $-1.35 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Personalis Inc:

  • The MRQ is -135.1%. The company is making a huge loss. -2
  • The TTM is -147.5%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-135.1%TTM-147.5%+12.4%
TTM-147.5%YOY-175.1%+27.6%
TTM-147.5%5Y-98.0%-49.5%
5Y-98.0%10Y-92.9%-5.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-135.1%-7.7%-127.4%
TTM-147.5%-6.7%-140.8%
YOY-175.1%2.4%-177.5%
5Y-98.0%-1.5%-96.5%
10Y-92.9%-3.4%-89.5%
1.1.2. Return on Assets

Shows how efficient Personalis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Personalis to the Diagnostics & Research industry mean.
  • -11.8% Return on Assets means that Personalis generated $-0.12 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Personalis Inc:

  • The MRQ is -11.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.8%TTM-11.2%-0.6%
TTM-11.2%YOY-8.5%-2.7%
TTM-11.2%5Y-6.9%-4.3%
5Y-6.9%10Y-6.1%-0.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.8%-1.7%-10.1%
TTM-11.2%-1.3%-9.9%
YOY-8.5%-0.9%-7.6%
5Y-6.9%-0.5%-6.4%
10Y-6.1%-0.9%-5.2%
1.1.3. Return on Equity

Shows how efficient Personalis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Personalis to the Diagnostics & Research industry mean.
  • -20.5% Return on Equity means Personalis generated $-0.21 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Personalis Inc:

  • The MRQ is -20.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-20.5%TTM-17.0%-3.5%
TTM-17.0%YOY-11.4%-5.7%
TTM-17.0%5Y-9.1%-8.0%
5Y-9.1%10Y-7.6%-1.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-20.5%-0.7%-19.8%
TTM-17.0%-0.1%-16.9%
YOY-11.4%0.3%-11.7%
5Y-9.1%-1.4%-7.7%
10Y-7.6%-2.3%-5.3%

1.2. Operating Efficiency of Personalis Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Personalis is operating .

  • Measures how much profit Personalis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Personalis to the Diagnostics & Research industry mean.
  • An Operating Margin of -101.3% means the company generated $-1.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Personalis Inc:

  • The MRQ is -101.3%. The company is operating very inefficient. -2
  • The TTM is -137.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-101.3%TTM-137.4%+36.1%
TTM-137.4%YOY-178.5%+41.1%
TTM-137.4%5Y-96.4%-41.1%
5Y-96.4%10Y-88.7%-7.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-101.3%-6.2%-95.1%
TTM-137.4%0.5%-137.9%
YOY-178.5%4.3%-182.8%
5Y-96.4%3.7%-100.1%
10Y-88.7%-1.3%-87.4%
1.2.2. Operating Ratio

Measures how efficient Personalis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.01 means that the operating costs are $2.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Personalis Inc:

  • The MRQ is 2.013. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.320. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.013TTM2.320-0.307
TTM2.320YOY2.785-0.465
TTM2.3205Y1.950+0.370
5Y1.95010Y1.877+0.073
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0131.296+0.717
TTM2.3201.301+1.019
YOY2.7851.238+1.547
5Y1.9501.268+0.682
10Y1.8771.217+0.660

1.3. Liquidity of Personalis Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Personalis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 3.00 means the company has $3.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Personalis Inc:

  • The MRQ is 3.005. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.638. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.005TTM4.638-1.633
TTM4.638YOY6.562-1.925
TTM4.6385Y5.705-1.067
5Y5.70510Y4.775+0.930
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ3.0052.111+0.894
TTM4.6382.298+2.340
YOY6.5622.581+3.981
5Y5.7053.012+2.693
10Y4.7753.081+1.694
1.3.2. Quick Ratio

Measures if Personalis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Personalis to the Diagnostics & Research industry mean.
  • A Quick Ratio of 4.00 means the company can pay off $4.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Personalis Inc:

  • The MRQ is 4.004. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.722. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.004TTM5.722-1.718
TTM5.722YOY9.545-3.823
TTM5.7225Y8.279-2.557
5Y8.27910Y6.916+1.362
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0041.204+2.800
TTM5.7221.285+4.437
YOY9.5451.565+7.980
5Y8.2791.925+6.354
10Y6.9162.128+4.788

1.4. Solvency of Personalis Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Personalis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Personalis to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.42 means that Personalis assets are financed with 42.5% credit (debt) and the remaining percentage (100% - 42.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Personalis Inc:

  • The MRQ is 0.425. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.335. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.425TTM0.335+0.090
TTM0.335YOY0.250+0.085
TTM0.3355Y0.323+0.012
5Y0.32310Y0.417-0.094
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4250.421+0.004
TTM0.3350.407-0.072
YOY0.2500.394-0.144
5Y0.3230.448-0.125
10Y0.4170.446-0.029
1.4.2. Debt to Equity Ratio

Measures if Personalis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Personalis to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 73.9% means that company has $0.74 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Personalis Inc:

  • The MRQ is 0.739. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.514. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.739TTM0.514+0.225
TTM0.514YOY0.333+0.181
TTM0.5145Y0.365+0.149
5Y0.36510Y0.304+0.061
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7390.606+0.133
TTM0.5140.567-0.053
YOY0.3330.631-0.298
5Y0.3650.658-0.293
10Y0.3040.742-0.438

2. Market Valuation of Personalis Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Personalis generates.

  • Above 15 is considered overpriced but always compare Personalis to the Diagnostics & Research industry mean.
  • A PE ratio of -1.00 means the investor is paying $-1.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Personalis Inc:

  • The EOD is -0.617. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.997. Based on the earnings, the company is expensive. -2
  • The TTM is -0.932. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.617MRQ-0.997+0.380
MRQ-0.997TTM-0.932-0.065
TTM-0.932YOY-1.867+0.934
TTM-0.9325Y-13.923+12.991
5Y-13.92310Y-11.603-2.321
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.617-0.261-0.356
MRQ-0.997-0.409-0.588
TTM-0.932-0.341-0.591
YOY-1.8670.002-1.869
5Y-13.9234.832-18.755
10Y-11.6035.198-16.801
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Personalis Inc:

  • The EOD is -0.969. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.565. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.506. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.969MRQ-1.565+0.596
MRQ-1.565TTM-1.506-0.059
TTM-1.506YOY-2.079+0.573
TTM-1.5065Y-0.366-1.140
5Y-0.36610Y-0.305-0.061
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.969-0.291-0.678
MRQ-1.565-0.441-1.124
TTM-1.506-1.388-0.118
YOY-2.079-2.0790.000
5Y-0.366-1.446+1.080
10Y-0.305-1.971+1.666
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Personalis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.82 means the investor is paying $0.82 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Personalis Inc:

  • The EOD is 0.507. Based on the equity, the company is cheap. +2
  • The MRQ is 0.819. Based on the equity, the company is cheap. +2
  • The TTM is 0.621. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.507MRQ0.819-0.312
MRQ0.819TTM0.621+0.199
TTM0.621YOY0.795-0.174
TTM0.6215Y3.392-2.772
5Y3.39210Y2.827+0.565
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.5071.857-1.350
MRQ0.8192.228-1.409
TTM0.6212.222-1.601
YOY0.7953.104-2.309
5Y3.3923.447-0.055
10Y2.8274.036-1.209
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Personalis Inc.

3.1. Institutions holding Personalis Inc

Institutions are holding 60.05% of the shares of Personalis Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ARK Investment Management LLC13.210.083667154595211816.6471
2023-12-31BlackRock Inc6.56440.00023315268-14610-0.4388
2023-12-31Vanguard Group Inc4.09890.0001207009444930.2175
2023-09-30Alyeska Investment Group, L.P.2.46650.0102124566800
2023-12-31Nikko Asset Management Americas Inc2.14570.0217108368500
2023-12-31Sumitomo Mitsui Trust Holdings Inc2.14570.0017108368500
2023-12-31Renaissance Technologies Corp1.66480.002784081128833652.1899
2023-12-31Acadian Asset Management LLC1.030.004252018214504538.6645
2023-12-31Wellington Shields Capital Mgmt LLC0.94610.1252477831-179906-27.3523
2023-09-30Jacobs Levy Equity Management, Inc.0.88090.0032444903-62658-12.3449
2023-12-31State Treasurer State Of Michigan0.87870.005544379800
2023-12-31GSA Capital Partners LLP0.78340.0699395643258285188.0378
2023-12-31Geode Capital Management, LLC0.77160.0001389709178114.7892
2023-09-30D. E. Shaw & Co LP0.7650.0005386341-31321-7.4991
2023-12-31Pacific Heights Asset Management, LLC0.61380.055831000000
2023-12-31Bruce & Co Inc0.5940.2198300000150000100
2023-12-31Wellington Shields & Co., LLC0.59260.1493299297-304970-50.4694
2023-12-31Millennium Management LLC0.52850.0002266897152003132.2985
2023-12-31LPL Financial Corp0.38210.0003192953-1186-0.6109
2023-12-31Goldman Sachs Group Inc0.37240188088143277319.7362
Total 41.43510.753620926398+1516717+7.2%

3.2. Funds holding Personalis Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31ARK Genomic Revolution11.89290.55696006369-606197-9.1673
2024-03-28ARK Genomic Revolution ETF11.83840.55615978857491420.8287
2024-02-29Vanguard Total Stock Mkt Idx Inv2.40380.00011213997-161376-11.7333
2024-02-29BlackRock Advantage Small Cap Core Instl1.34220.0299677851-1902-0.2798
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.06780.000853927900
2023-12-31Bruce0.5940.1386300000150000100
2024-02-29Fidelity Extended Market Index0.43320.0009218801-1060-0.4821
2024-03-31Blackrock Russell 2000 Alpha Tilts Fd A0.33470.026416902541252.5015
2024-02-29BlackRock Advantage SMID Cap Instl0.2940.0562148482-2034-1.3514
2023-12-31Bridgeway Ultra-Small Company Market0.25640.1464129500-25000-16.1812
2024-02-29BlackRock Advantage Small Cap Gr Instl0.25340.034412798900
2023-12-31Vanguard Explorer Inv0.19030.00099611800
2024-03-28iShares Micro-Cap ETF0.17220.01418698200
2024-01-31BlackRock Advantage SMID Cap V.I. Fd I0.16490.072883300-4066-4.654
2023-09-30BlackRock Extended Mkt Composite0.15710.00077932500
2024-02-29Fidelity Total Market Index0.13890.00017014200
2024-03-31BlackRock Extended Equity Market K0.13710.000769229250.0361
2024-02-29Fidelity Series Total Market Index0.10390.00015249600
2023-09-20BlackRock US SmCp Eq BigData Strat MF0.1010.06025100036700256.6434
2023-12-31NT Ext Equity Mkt Idx Fd - L0.07820.0014395081315849.9355
Total 31.95441.697716138250-548485-3.4%

3.3. Insider Transactions

Insiders are holding 2.154% of the shares of Personalis Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-29Richard ChenSELL5261.37
2024-01-29Aaron TachibanaSELL7161.37
2023-12-15Aaron TachibanaSELL67471.47
2023-12-15Richard ChenSELL47081.47
2023-12-15Stephen Michael MooreSELL14761.47
2023-11-16Aaron TachibanaSELL13441.04
2023-11-16Richard ChenSELL9401.04
2023-11-16Stephen Michael MooreSELL17221.04
2023-11-01Christopher M HallSELL204590.93
2023-07-31Aaron TachibanaSELL6622.26
2023-07-31Richard ChenSELL4852.26
2023-06-16Aaron TachibanaSELL69042.07
2023-06-16Richard ChenSELL48172.07
2023-06-16Stephen Michael MooreSELL15092.07
2023-05-17Aaron TachibanaSELL13891.98
2023-05-17Richard ChenSELL9711.98
2023-05-17Stephen Michael MooreSELL17811.98
2023-05-02Stephen Michael MooreSELL51022.29

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Personalis Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.431-0.439+2%-0.456+6%0.233-285%0.107-504%
Book Value Per Share--2.5633.219-20%5.009-49%3.852-33%3.122-18%
Current Ratio--3.0054.638-35%6.562-54%5.705-47%4.775-37%
Debt To Asset Ratio--0.4250.335+27%0.250+70%0.323+32%0.417+2%
Debt To Equity Ratio--0.7390.514+44%0.333+122%0.365+102%0.304+143%
Dividend Per Share----0%-0%-0%-0%
Eps---0.526-0.536+2%-0.561+7%-0.350-34%-0.308-42%
Free Cash Flow Per Share---0.335-0.332-1%-0.595+77%-0.338+1%-0.284-15%
Free Cash Flow To Equity Per Share---0.141-0.273+94%-0.588+317%0.097-246%0.078-280%
Gross Profit Margin--1.0001.0000%1.0000%1.070-7%1.058-6%
Intrinsic Value_10Y_max---30.407--------
Intrinsic Value_10Y_min---25.884--------
Intrinsic Value_1Y_max---1.963--------
Intrinsic Value_1Y_min---1.928--------
Intrinsic Value_3Y_max---6.725--------
Intrinsic Value_3Y_min---6.404--------
Intrinsic Value_5Y_max---12.482--------
Intrinsic Value_5Y_min---11.515--------
Market Cap65655070.000-62%106058190.000100376501.250+6%209464925.250-49%606059425.975-83%505049521.646-79%
Net Profit Margin---1.351-1.475+9%-1.751+30%-0.980-27%-0.929-31%
Operating Margin---1.013-1.374+36%-1.785+76%-0.964-5%-0.887-12%
Operating Ratio--2.0132.320-13%2.785-28%1.950+3%1.877+7%
Pb Ratio0.507-62%0.8190.621+32%0.795+3%3.392-76%2.827-71%
Pe Ratio-0.617+38%-0.997-0.932-7%-1.867+87%-13.923+1296%-11.603+1063%
Price Per Share1.300-62%2.1001.988+6%4.148-49%12.000-83%10.000-79%
Price To Free Cash Flow Ratio-0.969+38%-1.565-1.506-4%-2.079+33%-0.366-77%-0.305-81%
Price To Total Gains Ratio-3.017+38%-4.873-4.607-5%-9.074+86%-47.644+878%-47.644+878%
Quick Ratio--4.0045.722-30%9.545-58%8.279-52%6.916-42%
Return On Assets---0.118-0.112-5%-0.085-28%-0.069-41%-0.061-48%
Return On Equity---0.205-0.170-17%-0.114-45%-0.091-56%-0.076-63%
Total Gains Per Share---0.431-0.439+2%-0.456+6%0.233-285%0.107-504%
Usd Book Value--129441000.000162591250.000-20%252971250.000-49%194531500.000-33%157676750.000-18%
Usd Book Value Change Per Share---0.431-0.439+2%-0.456+6%0.233-285%0.107-504%
Usd Book Value Per Share--2.5633.219-20%5.009-49%3.852-33%3.122-18%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.526-0.536+2%-0.561+7%-0.350-34%-0.308-42%
Usd Free Cash Flow---16942000.000-16792250.000-1%-30032250.000+77%-17077950.000+1%-14326625.000-15%
Usd Free Cash Flow Per Share---0.335-0.332-1%-0.595+77%-0.338+1%-0.284-15%
Usd Free Cash Flow To Equity Per Share---0.141-0.273+94%-0.588+317%0.097-246%0.078-280%
Usd Market Cap65655070.000-62%106058190.000100376501.250+6%209464925.250-49%606059425.975-83%505049521.646-79%
Usd Price Per Share1.300-62%2.1001.988+6%4.148-49%12.000-83%10.000-79%
Usd Profit---26584000.000-27074000.000+2%-28328750.000+7%-17660050.000-34%-15545291.667-42%
Usd Revenue--19675000.00018370250.000+7%16261750.000+21%18393850.000+7%16902125.000+16%
Usd Total Gains Per Share---0.431-0.439+2%-0.456+6%0.233-285%0.107-504%
 EOD+3 -5MRQTTM+18 -15YOY+18 -155Y+8 -2610Y+5 -29

4.2. Fundamental Score

Let's check the fundamental score of Personalis Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.617
Price to Book Ratio (EOD)Between0-10.507
Net Profit Margin (MRQ)Greater than0-1.351
Operating Margin (MRQ)Greater than0-1.013
Quick Ratio (MRQ)Greater than14.004
Current Ratio (MRQ)Greater than13.005
Debt to Asset Ratio (MRQ)Less than10.425
Debt to Equity Ratio (MRQ)Less than10.739
Return on Equity (MRQ)Greater than0.15-0.205
Return on Assets (MRQ)Greater than0.05-0.118
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Personalis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.380
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets225,099
Total Liabilities95,658
Total Stockholder Equity129,441
 As reported
Total Liabilities 95,658
Total Stockholder Equity+ 129,441
Total Assets = 225,099

Assets

Total Assets225,099
Total Current Assets141,931
Long-term Assets83,168
Total Current Assets
Cash And Cash Equivalents 56,984
Short-term Investments 57,195
Net Receivables 17,730
Inventory 5,661
Other Current Assets 4,361
Total Current Assets  (as reported)141,931
Total Current Assets  (calculated)141,931
+/-0
Long-term Assets
Property Plant Equipment 75,218
Long-term Assets Other 6,160
Long-term Assets  (as reported)83,168
Long-term Assets  (calculated)81,378
+/- 1,790

Liabilities & Shareholders' Equity

Total Current Liabilities47,234
Long-term Liabilities48,424
Total Stockholder Equity129,441
Total Current Liabilities
Short-term Debt 9,407
Short Long Term Debt 1,646
Accounts payable 14,920
Other Current Liabilities 19,619
Total Current Liabilities  (as reported)47,234
Total Current Liabilities  (calculated)45,592
+/- 1,642
Long-term Liabilities
Capital Lease Obligations 46,082
Long-term Liabilities  (as reported)48,424
Long-term Liabilities  (calculated)46,082
+/- 2,342
Total Stockholder Equity
Common Stock5
Retained Earnings -468,706
Accumulated Other Comprehensive Income -222
Other Stockholders Equity 598,364
Total Stockholder Equity (as reported)129,441
Total Stockholder Equity (calculated)129,441
+/-0
Other
Capital Stock5
Cash and Short Term Investments 114,179
Common Stock Shares Outstanding 49,597
Current Deferred Revenue3,288
Liabilities and Stockholders Equity 225,099
Net Debt -8,022
Net Invested Capital 131,087
Net Working Capital 99,510
Property Plant and Equipment Gross 112,886
Short Long Term Debt Total 48,962



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-31
> Total Assets 
0
0
0
41,670
57,655
191,845
159,691
157,291
151,878
145,522
248,812
244,842
395,506
383,340
406,694
396,528
380,647
357,979
317,861
292,700
272,180
249,038
226,636
225,099
225,099226,636249,038272,180292,700317,861357,979380,647396,528406,694383,340395,506244,842248,812145,522151,878157,291159,691191,84557,65541,670000
   > Total Current Assets 
0
0
0
29,559
42,931
176,169
140,298
139,578
135,416
120,121
223,593
220,719
372,668
354,309
329,015
318,231
294,028
260,040
221,908
199,699
182,772
160,955
148,215
141,931
141,931148,215160,955182,772199,699221,908260,040294,028318,231329,015354,309372,668220,719223,593120,121135,416139,578140,298176,16942,93129,559000
       Cash And Cash Equivalents 
0
0
0
19,744
33,245
163,269
87,013
55,046
46,694
25,042
133,245
68,525
137,089
70,080
79,572
105,585
91,586
86,731
83,522
89,128
87,172
97,195
72,192
56,984
56,98472,19297,19587,17289,12883,52286,73191,586105,58579,57270,080137,08968,525133,24525,04246,69455,04687,013163,26933,24519,744000
       Short-term Investments 
0
0
0
0
0
0
40,263
73,243
73,339
80,191
72,818
134,765
216,340
258,827
225,658
181,479
174,954
146,759
109,234
78,530
61,767
40,012
48,471
57,195
57,19548,47140,01261,76778,530109,234146,759174,954181,479225,658258,827216,340134,76572,81880,19173,33973,24340,263000000
       Net Receivables 
0
0
0
4,457
3,110
7,465
4,445
3,300
5,508
5,375
5,903
6,349
8,053
9,278
10,534
18,468
13,519
12,877
13,592
16,642
18,103
10,132
13,666
17,730
17,73013,66610,13218,10316,64213,59212,87713,51918,46810,5349,2788,0536,3495,9035,3755,5083,3004,4457,4653,1104,457000
       Other Current Assets 
0
0
0
1,926
3,692
1,897
3,973
3,383
3,437
2,989
5,359
5,441
5,607
8,803
7,728
7,089
9,151
7,166
9,696
6,808
7,511
5,476
5,661
4,361
4,3615,6615,4767,5116,8089,6967,1669,1517,0897,7288,8035,6075,4415,3592,9893,4373,3833,9731,8973,6921,926000
   > Long-term Assets 
0
0
0
12,111
14,724
15,676
19,393
17,713
16,462
25,401
25,219
24,123
22,838
29,031
77,679
78,297
86,619
97,939
95,953
93,001
89,408
88,083
78,421
83,168
83,16878,42188,08389,40893,00195,95397,93986,61978,29777,67929,03122,83824,12325,21925,40116,46217,71319,39315,67614,72412,111000
       Property Plant Equipment 
0
0
0
11,452
13,755
14,729
17,369
15,951
14,931
23,641
23,367
22,105
21,051
25,384
72,612
73,472
82,327
93,500
91,264
88,415
85,417
84,146
74,918
75,218
75,21874,91884,14685,41788,41591,26493,50082,32773,47272,61225,38421,05122,10523,36723,64114,93115,95117,36914,72913,75511,452000
       Other Assets 
0
0
0
0
969
947
2,024
1,762
1,531
1,760
1,852
12,289
1,787
3,647
5,067
4,825
4,292
4,439
4,689
4,586
0
3,937
3,503
0
03,5033,93704,5864,6894,4394,2924,8255,0673,6471,78712,2891,8521,7601,5311,7622,0249479690000
> Total Liabilities 
0
0
0
148,058
77,949
74,827
48,299
50,601
52,676
52,399
45,272
49,897
47,086
44,593
81,398
86,227
93,932
93,347
75,462
74,561
78,548
72,952
75,430
95,658
95,65875,43072,95278,54874,56175,46293,34793,93286,22781,39844,59347,08649,89745,27252,39952,67650,60148,29974,82777,949148,058000
   > Total Current Liabilities 
0
0
0
57,850
58,271
56,343
47,389
49,962
52,120
43,037
35,904
40,636
38,564
34,087
26,516
31,313
39,844
41,506
33,739
33,131
34,143
28,592
32,478
47,234
47,23432,47828,59234,14333,13133,73941,50639,84431,31326,51634,08738,56440,63635,90443,03752,12049,96247,38956,34358,27157,850000
       Short-term Debt 
0
0
0
4,996
1,000
2,050
1,421
1,361
1,107
2,107
2,302
2,445
2,469
6,146
5,327
5,534
5,973
6,385
7,112
7,609
8,786
8,073
-3,694
9,407
9,407-3,6948,0738,7867,6097,1126,3855,9735,5345,3276,1462,4692,4452,3022,1071,1071,3611,4212,0501,0004,996000
       Short Long Term Debt 
0
0
0
0
1,000
1,020
0
0
0
0
0
0
0
2,786
1,775
1,806
1,836
1,745
2,178
2,218
2,257
430
403
1,646
1,6464034302,2572,2182,1781,7451,8361,8061,7752,78600000001,0201,0000000
       Accounts payable 
0
0
0
6,565
7,997
8,781
7,764
7,337
10,337
7,491
6,514
8,301
6,522
8,919
7,288
9,221
12,275
21,395
10,784
12,854
10,927
8,847
8,963
14,920
14,9208,9638,84710,92712,85410,78421,39512,2759,2217,2888,9196,5228,3016,5147,49110,3377,3377,7648,7817,9976,565000
       Other Current Liabilities 
0
0
0
3,389
5,951
3,638
4,478
5,287
6,268
4,487
6,495
8,856
11,336
7,562
10,934
12,576
18,105
13,340
15,516
11,404
11,837
8,313
23,515
19,619
19,61923,5158,31311,83711,40415,51613,34018,10512,57610,9347,56211,3368,8566,4954,4876,2685,2874,4783,6385,9513,389000
   > Long-term Liabilities 
0
0
0
90,208
19,678
18,484
910
639
556
9,362
9,368
9,261
8,522
10,506
54,882
54,914
54,088
51,841
41,723
41,430
44,405
44,360
42,952
48,424
48,42442,95244,36044,40541,43041,72351,84154,08854,91454,88210,5068,5229,2619,3689,36255663991018,48419,67890,208000
       Long term Debt Total 
0
0
0
0
19,758
18,016
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000018,01619,7580000
       Other Liabilities 
0
0
0
0
37
0
910
0
556
129
471
720
360
1,988
356
2,117
8
5
374
11
0
3,639
3,786
0
03,7863,639011374582,1173561,98836072047112955609100370000
> Total Stockholder Equity
-92,603
0
0
-106,388
-20,294
117,018
111,392
106,690
99,202
93,123
203,540
194,945
348,420
338,747
325,296
310,301
286,715
264,632
242,399
218,139
193,632
176,086
151,206
129,441
129,441151,206176,086193,632218,139242,399264,632286,715310,301325,296338,747348,420194,945203,54093,12399,202106,690111,392117,018-20,294-106,38800-92,603
   Common Stock
0
0
0
1
2
3
3
3
3
3
4
4
4
4
4
4
5
5
5
5
5
5
5
5
555555554444443333321000
   Retained Earnings Total Equity00-413,024-389,069-360,410-329,342-302,850-275,304-247,095-226,896-209,226-194,273-181,86900000000000
   Accumulated Other Comprehensive Income 
0
0
0
-15
-6,251
-15
-29
-6
73
106
37
22
-5
18
12
-166
-875
-1,264
-1,422
-912
-455
-313
-302
-222
-222-302-313-455-912-1,422-1,264-875-1661218-5223710673-6-29-15-6,251-15000
   Capital Surplus 
0
0
0
0
10,666
244,089
245,362
247,282
248,854
0
0
376,788
542,694
547,951
552,176
557,558
562,889
568,741
573,158
579,456
583,151
589,418
0
0
00589,418583,151579,456573,158568,741562,889557,558552,176547,951542,694376,78800248,854247,282245,362244,08910,6660000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
14,320
108,035
52,244
85,671
247,282
248,854
251,997
372,027
376,788
542,694
547,951
552,176
557,558
562,889
568,741
573,158
579,456
583,151
589,418
593,625
598,364
598,364593,625589,418583,151579,456573,158568,741562,889557,558552,176547,951542,694376,788372,027251,997248,854247,28285,67152,244108,03514,320000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue73,481
Cost of Revenue-55,273
Gross Profit18,20818,208
 
Operating Income (+$)
Gross Profit18,208
Operating Expense-114,502
Operating Income-96,294-96,294
 
Operating Expense (+$)
Research Development64,776
Selling General Administrative49,726
Selling And Marketing Expenses0
Operating Expense114,502114,502
 
Net Interest Income (+$)
Interest Income5,901
Interest Expense-110
Other Finance Cost-0
Net Interest Income5,791
 
Pretax Income (+$)
Operating Income-96,294
Net Interest Income5,791
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-108,213-84,375
EBIT - interestExpense = -96,404
-108,213
-108,186
Interest Expense110
Earnings Before Interest and Taxes (EBIT)-96,294-108,103
Earnings Before Interest and Taxes (EBITDA)-84,998
 
After tax Income (+$)
Income Before Tax-108,213
Tax Provision-83
Net Income From Continuing Ops-108,296-108,296
Net Income-108,296
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses169,775
Total Other Income/Expenses Net-11,919-5,791
 

Technical Analysis of Personalis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Personalis. The general trend of Personalis is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Personalis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Personalis Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.31 < 1.34 < 1.54.

The bearish price targets are: 1.12 > 0.92 > 0.92.

Tweet this
Personalis Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Personalis Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Personalis Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Personalis Inc.

Personalis Inc Daily Moving Average Convergence/Divergence (MACD) ChartPersonalis Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Personalis Inc. The current adx is .

Personalis Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Personalis Inc.

Personalis Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Personalis Inc.

Personalis Inc Daily Relative Strength Index (RSI) ChartPersonalis Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Personalis Inc.

Personalis Inc Daily Stochastic Oscillator ChartPersonalis Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Personalis Inc.

Personalis Inc Daily Commodity Channel Index (CCI) ChartPersonalis Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Personalis Inc.

Personalis Inc Daily Chande Momentum Oscillator (CMO) ChartPersonalis Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Personalis Inc.

Personalis Inc Daily Williams %R ChartPersonalis Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Personalis Inc.

Personalis Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Personalis Inc.

Personalis Inc Daily Average True Range (ATR) ChartPersonalis Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Personalis Inc.

Personalis Inc Daily On-Balance Volume (OBV) ChartPersonalis Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Personalis Inc.

Personalis Inc Daily Money Flow Index (MFI) ChartPersonalis Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Personalis Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Personalis Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Personalis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.380
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Personalis with someone you think should read this too:
  • Are you bullish or bearish on Personalis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Personalis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Personalis Inc

I send you an email if I find something interesting about Personalis Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Personalis Inc.

Receive notifications about Personalis Inc in your mailbox!